Daniele Piomelli, PhD (IMAGE)
Caption
“This study is the first to identify that NAAA, a previously unrecognized control node, can be effectively targeted by small-molecule therapeutics that inhibit this enzyme, and block the transition from acute to chronic pain,” said Daniele Piomelli, PhD, Distinguished Professor in the UCI School of Medicine Department of Anatomy & Neurobiology.
Credit
UCI School of Medicine
Usage Restrictions
No restriction
License
Original content